COLBY CRAWFORD: Open Payments
NPI 1619273547 · GRAND JUNCTION, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 31 payments from 11 companies in 2025. Trend: 2023 $214 · 2024 $510 · 2025 $654
Food & beverage: $634Education: $20
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $163 |
| Tactile Systems Technology Inc | 3 | $129 |
| GENZYME CORPORATION | 4 | $93 |
| ABBVIE INC. | 5 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| KLS-Martin L.P. | 1 | $35 |
| Amgen Inc. | 2 | $34 |
| AERIN MEDICAL INC. | 1 | $27 |
| Smith+Nephew, Inc. | 1 | $22 |
| Medtronic, Inc. | 1 | $19 |
Products named: NUCALA, DUPIXENT, Flexitouch Plus, QULIPTA, TAVNEOS, VIVAER STYLUS, TULA, PROPEL.
Industry payments across CO — which companies pay providers there.
